Annual Current Liabilities
$42.55 M
-$4.18 M-8.94%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual total current liabilities is $42.55 million, with the most recent change of -$4.18 million (-8.94%) on September 30, 2024.
- During the last 3 years, OTLK annual current liabilities has risen by +$35.80 million (+530.22%).
- OTLK annual current liabilities is now -8.94% below its all-time high of $46.73 million, reached on September 30, 2023.
Performance
OTLK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$42.55 M
-$100.000.00%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly total current liabilities is $42.55 million, with the most recent change of -$100.00 (0.00%) on September 1, 2024.
- Over the past year, OTLK quarterly current liabilities has dropped by -$3.42 million (-7.43%).
- OTLK quarterly current liabilities is now -21.31% below its all-time high of $54.08 million, reached on March 31, 2024.
Performance
OTLK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
OTLK Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.9% | -7.4% |
| 3 y3 years | +530.2% | +530.2% |
| 5 y5 years | +109.7% | +79.5% |
OTLK Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | +530.2% | -21.3% | +182.2% |
| 5 y | 5-year | -8.9% | +530.2% | -21.3% | +530.2% |
| alltime | all time | -8.9% | +530.2% | -21.3% | +530.2% |
Outlook Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $42.55 M(-8.9%) | - |
| Sep 2024 | - | $42.55 M(-0.0%) |
| Jun 2024 | - | $42.55 M(-21.3%) |
| Mar 2024 | - | $54.08 M(+17.6%) |
| Dec 2023 | - | $45.97 M(-1.6%) |
| Sep 2023 | $46.73 M(+136.9%) | $46.73 M(-6.4%) |
| Jun 2023 | - | $49.93 M(+14.7%) |
| Mar 2023 | - | $43.53 M(+188.6%) |
| Dec 2022 | - | $15.08 M(-23.6%) |
| Sep 2022 | $19.73 M(+192.2%) | $19.73 M(+7.1%) |
| Jun 2022 | - | $18.43 M(-41.3%) |
| Mar 2022 | - | $31.41 M(+57.5%) |
| Dec 2021 | - | $19.95 M(+195.4%) |
| Sep 2021 | $6.75 M(-57.5%) | $6.75 M(-65.6%) |
| Jun 2021 | - | $19.64 M(-17.8%) |
| Mar 2021 | - | $23.90 M(+97.1%) |
| Dec 2020 | - | $12.12 M(-23.7%) |
| Sep 2020 | $15.89 M | $15.89 M(-13.9%) |
| Jun 2020 | - | $18.45 M(-22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $23.71 M(+17.9%) |
| Dec 2019 | - | $20.10 M(-0.9%) |
| Sep 2019 | $20.29 M(-36.7%) | $20.29 M(-12.6%) |
| Jun 2019 | - | $23.22 M(-14.0%) |
| Mar 2019 | - | $26.99 M(-2.0%) |
| Dec 2018 | - | $27.54 M(-14.1%) |
| Sep 2018 | $32.04 M(+11.5%) | $32.04 M(-0.7%) |
| Jun 2018 | - | $32.26 M(+1.6%) |
| Mar 2018 | - | $31.75 M(+1.8%) |
| Dec 2017 | - | $31.20 M(+8.6%) |
| Sep 2017 | $28.74 M(+40.6%) | $28.74 M(-26.8%) |
| Jun 2017 | - | $39.27 M(+12.9%) |
| Mar 2017 | - | $34.78 M(+8.2%) |
| Dec 2016 | - | $32.13 M(+57.2%) |
| Sep 2016 | $20.44 M(-44.8%) | $20.44 M(-10.9%) |
| Jun 2016 | - | $22.94 M(-36.2%) |
| Mar 2016 | - | $35.98 M(+0.6%) |
| Dec 2015 | - | $35.76 M(-3.5%) |
| Sep 2015 | $37.04 M(0.0%) | $37.04 M |
| Sep 2014 | $37.04 M | - |
FAQ
- What is Outlook Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Outlook Therapeutics?
- What is Outlook Therapeutics annual current liabilities year-on-year change?
- What is Outlook Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly current liabilities year-on-year change?
What is Outlook Therapeutics annual total current liabilities?
The current annual current liabilities of OTLK is $42.55 M
What is the all time high annual current liabilities for Outlook Therapeutics?
Outlook Therapeutics all-time high annual total current liabilities is $46.73 M
What is Outlook Therapeutics annual current liabilities year-on-year change?
Over the past year, OTLK annual total current liabilities has changed by -$4.18 M (-8.94%)
What is Outlook Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of OTLK is $42.55 M
What is the all time high quarterly current liabilities for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly total current liabilities is $54.08 M
What is Outlook Therapeutics quarterly current liabilities year-on-year change?
Over the past year, OTLK quarterly total current liabilities has changed by -$3.42 M (-7.43%)